UCB leadership discusses how bridging regulatory approval and real-world access requires integrated care coordination and a long-term commitment to the patient journey.
Brad Chapman
Advertisement
Brad Chapman is the head of US Epilepsy and Rare Syndromes at UCB.
Articles by Brad Chapman
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation
2
Colleen Cotton, MD, on the importance of early recognition in hidradenitis suppurativa
3
FDA approves ensitrelvir for post-exposure prevention of COVID-19 in adolescents and adults
4
FDA accepts mavacamten (Camzyos) application for adolescent obstructive hypertrophic cardiomyopathy
5